8-K: Colgate-Palmolive Reports Strong Q3 2026 Results

Colgate-Palmolive announced robust third-quarter 2026 results, with net sales up 4.6% and organic sales up 3.6%, driven by broad-based growth across categories and divisions.

Summary

• Colgate-Palmolive reported a 4.6% increase in net sales to $5,369 million and a 3.6% increase in organic sales for the third quarter of 2026.
• Diluted Earnings Per Share (EPS) on a GAAP basis increased by 3% to $0.94, while Base Business EPS (non-GAAP) rose by 7% to $0.97.
• Gross profit margin improved by 80 basis points to 60.2% (GAAP) and by 90 basis points to 60.3% (Base Business).
• Net cash provided by operations for the first nine months of 2026 was $2,913 million.
• Global market share in toothpaste remained strong at 41.4% year-to-date, and manual toothbrushes at 33.1% year-to-date.
• The company narrowed its sales guidance and raised its gross profit margin and Base Business EPS guidance for the full year 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with the company demonstrating solid sales growth and improved profitability, alongside an upward revision of its full-year guidance.

Positives

• Net sales increased by 4.6% to $5,369 million in Q3 2026.
• Organic sales grew by 3.6% in Q3 2026, indicating strong underlying business performance.
• Base Business EPS increased by 7% to $0.97, demonstrating improved operational profitability.
• Gross profit margin expanded by 80 basis points (GAAP) and 90 basis points (Base Business), showing enhanced efficiency.
• Full-year 2026 guidance was narrowed for net sales (now 4% to 5% growth) and raised for gross profit margin and Base Business EPS.
• Global market share leadership maintained in toothpaste (41.4%) and manual toothbrushes (33.1%).
• Net cash provided by operations for the first nine months of 2026 was $2,913 million, up from $2,745 million in the prior year.

Negatives

• North America division saw a net sales decrease of 1.7% and an operating profit decrease of 11% in Q3 2026.
• Asia Pacific division's operating profit decreased by 1% in Q3 2026.
• A 0.2% negative impact on organic sales was attributed to lower private label pet food sales.
• The company exited the private label pet food business, which will impact reported sales figures.

Risks

• Consumer uncertainty and ongoing macroeconomic volatility are noted as challenges.
• The company mentions the impact of geopolitical events and tensions, wars, and military conflicts, such as in Ukraine and the Middle East.
• Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those projected.
• Market share data is subject to limitations, including the availability of up-to-date information and the exclusion of certain retail channels like eCommerce.

Future Outlook

For the full year 2026, the company now expects net sales to be up 4% to 5% (previously 2% to 6%), including a low-single-digit positive impact from foreign exchange. Organic sales growth is expected to be broadly in line with the nine-month performance. The company anticipates an increase in gross profit margin (versus roughly flat previously) and double-digit earnings per share growth on a GAAP basis. On a non-GAAP (Base Business) basis, gross profit margin is also expected to increase, and earnings per share growth is now projected at 5% to 7% (versus mid-single-digit growth previously). Advertising spend is expected to increase on both a dollar basis and as a percentage of net sales.

Management Comments

• "Our growth momentum continued, delivering another strong quarter of broad-based topand bottom-line growth with net sales and organic sales increasing in all four categories and in four of five divisions."
• "We were particularly pleased to have delivered our fourth quarter of sequential improvement in worldwide volume growth, while delivering strong pricing growth in the third quarter."
• "As was the case last quarter, gross profit, gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increased year over year."
• "We remain focused on executing our 2030 strategy, with an emphasis on driving premium, science-based innovation, and we continue to invest behind our brands globally supported by another double-digit increase in advertising this quarter."
• "Despite consumer uncertainty and ongoing macroeconomic volatility, our proactive focus on driving growth while building flexibility into our P&L gives us confidence we can navigate these challenges while continuing to deliver consistent, compounded earnings per share growth and drive long-term shareholder value."

Industry Context

StockSavvy.ai notes that Colgate-Palmolive's performance in Q3 2026 aligns with a broader trend in the consumer staples sector of focusing on pricing power and premium innovation to offset inflationary pressures and maintain growth.

Comparison to Industry Standards

• Colgate-Palmolive's organic sales growth of 3.6% in Q3 2026 is solid within the consumer staples sector, where growth rates are typically more modest compared to high-growth industries. For instance, competitors like Procter & Gamble have also reported steady organic growth driven by pricing and innovation.
• The company's gross profit margin of 60.2% (GAAP) is exceptionally high, reflecting strong brand equity and efficient operations, often exceeding industry averages for packaged goods companies.
• The focus on premium, science-based innovation is a key strategy across the industry, with companies like Unilever and L'Oréal also heavily investing in R&D and product differentiation to capture higher-value market segments.

Legal Proceedings

• The company mentions charges related to the ERISA litigation matter in its non-GAAP reconciliations.

Stakeholder Impact

• Shareholders: The raised guidance and solid performance are likely to be viewed positively, potentially supporting shareholder value.
• Employees: Continued investment in brands and focus on growth may provide job security and opportunities.
• Customers: The emphasis on innovation and science-based products may lead to improved product offerings.
• Suppliers: Consistent demand and growth could lead to stable relationships with suppliers.

Next Steps

• Continue executing the 2030 strategy focused on premium, science-based innovation.
• Invest behind global brands with continued double-digit increases in advertising.
• Navigate consumer uncertainty and macroeconomic volatility.
• Deliver consistent, compounded earnings per share growth and drive long-term shareholder value.

Key Dates

Recommendation

The company delivered expected results with positive momentum and raised guidance, but the North American segment showed weakness, and broader macroeconomic uncertainties persist. While the performance is solid, it doesn't present a compelling catalyst for a significant upward re-rating at this moment, warranting a hold.

Keywords

Colgate-Palmolive, Q3 2026 Earnings, Organic Sales, EPS, Gross Profit Margin, Oral Care, Pet Nutrition, Consumer Goods